Alp Bio

iOrganBio

This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.

Parallel Bio

This company develops a drug discovery platform using human immune organoids and artificial intelligence for pharmaceutical and biotechnology partners.

Techbio 2.0

This company develops induced pluripotent stem cell models and artificial intelligence platforms to provide predictive drug discovery data for pharmaceutical and biotechnology researchers.

Immunara

This company develops biological foundation models and artificial intelligence to map immune system interactions for pharmaceutical and biotechnology researchers.

Axiom Bio

This company develops artificial intelligence models that predict drug toxicity to help pharmaceutical researchers identify safety risks early in the development process.

Skape.Bio

The company develops AI-designed biologic medicines targeting G protein-coupled receptors for the pharmaceutical industry.

Alceus

This company develops a platform that uses artificial intelligence to design therapeutic proteins and program immune cells for clinicians and researchers treating solid tumours.

Aizen Therapeutics

This company develops oral peptide therapeutics for patients with chronic immune disorders using an artificial intelligence platform for molecular design.